DNTH
Dianthus Therapeutics Inc.
98.40$
+1.9%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -4,033.3% | -453.0% | -1,304.4% | -1,253.9% | -6,338.9% | |
| – | – | – | – | – | 136.9% | 2.3% | 12.6% | 6.6% | 21.0% | |
| – | – | – | – | – | 4.3% | 23.7% | 102.6% | 206.8% | 1,119.5% | |
| – | – | – | – | – | 4.3% | 14.2% | – | – | – | |
| – | – | – | – | – | -103.4% | -25.8% | 172.0% | -5.6% | 821.5% | |
| – | – | – | – | – | 85.6% | 2.2% | 3.9% | 1.7% | 10.5% | |
| – | – | – | – | – | 2,942.3% | -932.2% | 716.7% | -4,600.0% | -6,033.1% | |
| – | – | – | – | – | – | – | – | – | 15.6% | |
| – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | – | |
| – | – | – | – | – | 6,070.5% | 1,506.6% | 4,726.6% | 4,099.8% | 13,758.6% | |
| – | – | – | – | – | 4,979.5% | 121.3% | 4,138.9% | -1,754.1% | 1,386.6% | |
| – | – | – | – | – | -4,118.9% | -455.2% | -1,308.2% | -1,255.6% | -6,349.4% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.